Immunovant (IMVT) Other Operating Expenses (2019 - 2023)
Immunovant (IMVT) reported Other Operating Expenses of $142.63 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 40.9% from $101.2 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Other Operating Expenses (2019 - 2023) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Immunovant's Other Operating Expenses came in at $498.09 million, up 28.8% year-over-year; for FY2026 (ended Mar 31, 2026), it was $456.66 million, up 26.5% from FY2025.
- Other Operating Expenses has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 46.1% (FY2021 to FY2026).
- By fiscal year, Other Operating Expenses came in at $360.92 million in FY2025 (+60.1%), $225.43 million in FY2024 (+32.4%), $170.26 million in FY2023 (+67.2%) and $101.81 million in FY2022 (+48.4%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Other Operating Expenses in data going back to fiscal Q3 2019.
- Year over year, Other Operating Expenses has now increased in each of the last ten quarters, with growth averaging 48.7% over the last eight quarters.
- The high point for year-over-year Other Operating Expenses in five years was fiscal Q1 2024 (growth of 121.9%); the low point was fiscal Q3 2024 (a decline of 7.5%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $142.29 million (Q4 2026), $98.92 million (Q3 2026) and $114.25 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Immunovant | 7.32 Bn | 4.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 12.50 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Mar 31, 2019 | -8.93 Mn |
API Access
Immunovant Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();